vs
Side-by-side financial comparison of Bluerock Homes Trust, Inc. (BHM) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $18.9M, roughly 1.1× Bluerock Homes Trust, Inc.). Sight Sciences, Inc. runs the higher net margin — -20.4% vs -50.1%, a 29.7% gap on every dollar of revenue. On growth, Bluerock Homes Trust, Inc. posted the faster year-over-year revenue change (35.9% vs 6.9%). Bluerock Homes Trust, Inc. produced more free cash flow last quarter ($10.4M vs $-2.0M). Over the past eight quarters, Bluerock Homes Trust, Inc.'s revenue compounded faster (30.1% CAGR vs 2.9%).
Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
BHM vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $20.4M |
| Net Profit | $-9.5M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | -48.8% | -18.0% |
| Net Margin | -50.1% | -20.4% |
| Revenue YoY | 35.9% | 6.9% |
| Net Profit YoY | -29.9% | 64.9% |
| EPS (diluted) | $-0.75 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $20.4M | ||
| Q3 25 | $16.6M | $19.9M | ||
| Q2 25 | $16.8M | $19.6M | ||
| Q1 25 | $16.4M | $17.5M | ||
| Q4 24 | $13.9M | $19.1M | ||
| Q3 24 | $12.7M | $20.2M | ||
| Q2 24 | $12.5M | $21.4M | ||
| Q1 24 | $11.2M | $19.3M |
| Q4 25 | $-9.5M | $-4.2M | ||
| Q3 25 | $-10.0M | $-8.2M | ||
| Q2 25 | $-5.8M | $-11.9M | ||
| Q1 25 | $-7.3M | $-14.2M | ||
| Q4 24 | $-7.3M | $-11.8M | ||
| Q3 24 | $3.5M | $-11.1M | ||
| Q2 24 | $-5.2M | $-12.3M | ||
| Q1 24 | $-3.2M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | -48.8% | -18.0% | ||
| Q3 25 | -57.6% | -39.7% | ||
| Q2 25 | -30.9% | -59.6% | ||
| Q1 25 | -42.6% | -79.2% | ||
| Q4 24 | -52.8% | -62.5% | ||
| Q3 24 | 27.9% | -55.7% | ||
| Q2 24 | -41.3% | -59.2% | ||
| Q1 24 | -28.4% | -76.4% |
| Q4 25 | -50.1% | -20.4% | ||
| Q3 25 | -60.0% | -41.0% | ||
| Q2 25 | -34.7% | -61.0% | ||
| Q1 25 | -44.7% | -80.8% | ||
| Q4 24 | -52.8% | -62.1% | ||
| Q3 24 | 27.9% | -54.9% | ||
| Q2 24 | -41.3% | -57.7% | ||
| Q1 24 | -28.4% | -84.4% |
| Q4 25 | $-0.75 | $-0.07 | ||
| Q3 25 | $-0.94 | $-0.16 | ||
| Q2 25 | $-0.66 | $-0.23 | ||
| Q1 25 | $-0.67 | $-0.28 | ||
| Q4 24 | $-0.65 | $-0.23 | ||
| Q3 24 | $0.24 | $-0.22 | ||
| Q2 24 | $-0.42 | $-0.25 | ||
| Q1 24 | $-0.27 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.6M | $92.0M |
| Total DebtLower is stronger | $428.4M | $42.4M |
| Stockholders' EquityBook value | $128.7M | $63.9M |
| Total Assets | $1.2B | $115.3M |
| Debt / EquityLower = less leverage | 3.33× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $169.6M | $92.0M | ||
| Q3 25 | $2.1M | $92.4M | ||
| Q2 25 | $4.2M | $101.5M | ||
| Q1 25 | $3.0M | $108.8M | ||
| Q4 24 | $115.2M | $120.4M | ||
| Q3 24 | $155.1M | $118.6M | ||
| Q2 24 | $116.0M | $118.2M | ||
| Q1 24 | $92.3M | $127.3M |
| Q4 25 | $428.4M | $42.4M | ||
| Q3 25 | $415.9M | $42.4M | ||
| Q2 25 | $338.6M | $42.4M | ||
| Q1 25 | $336.5M | $42.4M | ||
| Q4 24 | $373.8M | $40.0M | ||
| Q3 24 | $122.5M | $37.1M | ||
| Q2 24 | $119.7M | $35.0M | ||
| Q1 24 | $120.2M | $35.0M |
| Q4 25 | $128.7M | $63.9M | ||
| Q3 25 | $131.7M | $64.3M | ||
| Q2 25 | $135.3M | $70.0M | ||
| Q1 25 | $137.1M | $77.6M | ||
| Q4 24 | $139.1M | $87.5M | ||
| Q3 24 | $142.9M | $95.0M | ||
| Q2 24 | $142.5M | $101.6M | ||
| Q1 24 | $144.5M | $109.2M |
| Q4 25 | $1.2B | $115.3M | ||
| Q3 25 | $222.1M | $116.3M | ||
| Q2 25 | $220.3M | $122.0M | ||
| Q1 25 | $186.2M | $129.7M | ||
| Q4 24 | $967.0M | $142.8M | ||
| Q3 24 | $800.8M | $143.6M | ||
| Q2 24 | $756.2M | $149.7M | ||
| Q1 24 | $727.4M | $155.6M |
| Q4 25 | 3.33× | 0.66× | ||
| Q3 25 | 3.16× | 0.66× | ||
| Q2 25 | 2.50× | 0.61× | ||
| Q1 25 | 2.45× | 0.55× | ||
| Q4 24 | 2.69× | 0.46× | ||
| Q3 24 | 0.86× | 0.39× | ||
| Q2 24 | 0.84× | 0.34× | ||
| Q1 24 | 0.83× | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.8M | $-1.8M |
| Free Cash FlowOCF − Capex | $10.4M | $-2.0M |
| FCF MarginFCF / Revenue | 55.0% | -9.7% |
| Capex IntensityCapex / Revenue | 91.8% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $25.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.8M | $-1.8M | ||
| Q3 25 | $13.4M | $-8.7M | ||
| Q2 25 | $13.9M | $-7.5M | ||
| Q1 25 | $951.0K | $-11.6M | ||
| Q4 24 | $9.1M | $-3.5M | ||
| Q3 24 | $1.7M | $362.0K | ||
| Q2 24 | $1.3M | $-9.5M | ||
| Q1 24 | $1.1M | $-9.8M |
| Q4 25 | $10.4M | $-2.0M | ||
| Q3 25 | $8.7M | $-8.9M | ||
| Q2 25 | $8.8M | $-7.8M | ||
| Q1 25 | $-2.9M | — | ||
| Q4 24 | $-253.0K | $-3.6M | ||
| Q3 24 | $-601.0K | $311.0K | ||
| Q2 24 | $-654.0K | $-9.5M | ||
| Q1 24 | $-630.0K | $-9.9M |
| Q4 25 | 55.0% | -9.7% | ||
| Q3 25 | 52.4% | -44.7% | ||
| Q2 25 | 52.2% | -39.6% | ||
| Q1 25 | -17.6% | — | ||
| Q4 24 | -1.8% | -18.9% | ||
| Q3 24 | -4.7% | 1.5% | ||
| Q2 24 | -5.2% | -44.7% | ||
| Q1 24 | -5.6% | -51.4% |
| Q4 25 | 91.8% | 0.8% | ||
| Q3 25 | 28.5% | 0.9% | ||
| Q2 25 | 30.3% | 1.1% | ||
| Q1 25 | 23.4% | 0.0% | ||
| Q4 24 | 66.9% | 0.7% | ||
| Q3 24 | 18.0% | 0.3% | ||
| Q2 24 | 15.3% | 0.4% | ||
| Q1 24 | 15.5% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHM
| Residential Communities Segment | $11.4M | 61% |
| Scattered Single Family Homes Segment | $7.5M | 39% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
